Friday, August 21, 2026

Coupang Data Breach: U.S. Shareholders Seek ISDS Arbitration Against South Korea

Coupang's U.S. shareholders plan arbitration over a data breach, claiming South Korea's actions violate the Korea-U.S. FTA.

AITRICS: “Medical Artificial Intelligence (AI) is No Longer a Choice”

Medical AI must prove its real-world value. AITRICS focuses on tools that enhance decision-making and integrate into healthcare workflows.

Kim Jong Un, Vladimir Putin Hold Phone Talks on Strategic Partnership

Kim Jong Un and Vladimir Putin discussed strengthening cooperation in a recent phone call, highlighting their strategic partnership.

Tag: Aptose Biosciences

Hanmi Pharmaceutical completes acquisition of Aptose Biosciences

Hanmi Pharmaceutical has acquired Aptose Biosciences for $46.7 million, regaining rights to the cancer drug tuspetinib.

Top News

- Our Sponsors Ad -

Follow us